These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11274284)

  • 1. Guillain-Barré syndrome as presenting feature in a patient with lupus nephritis, with complete resolution after cyclophosphamide treatment.
    van Laarhoven HW; Rooyer FA; van Engelen BG; van Dalen R; Berden JH
    Nephrol Dial Transplant; 2001 Apr; 16(4):840-2. PubMed ID: 11274284
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria.
    Fu LW; Yang LY; Chen WP; Lin CY
    Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
    Ferrario L; Bellone M; Bozzolo E; Baldissera E; Sabbadini MG
    Rheumatology (Oxford); 2000 Feb; 39(2):218-220. PubMed ID: 10725082
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
    Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
    Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
    Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
    N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
    Grootscholten C; Snoek FJ; Bijl M; van Houwelingen HC; Derksen RH; Berden JH;
    J Rheumatol; 2007 Aug; 34(8):1699-707. PubMed ID: 17659757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive therapy in lupus nephritis.
    D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of proliferative lupus nephritis: a changing landscape.
    Adu D
    Kidney Int; 2006 Aug; 70(4):616-8. PubMed ID: 16900218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?
    Kallenberg CG
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii62-5. PubMed ID: 23253917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lupus nephritis--a work in progress.
    Falk RJ
    N Engl J Med; 2000 Oct; 343(16):1182-3. PubMed ID: 11036127
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
    Tse KC; Tang CS; Lio WI; Lam MF; Chan TM
    Lupus; 2006; 15(6):371-9. PubMed ID: 16830884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
    Chen YC; Cheng TT; Lai HM; Wu CH
    Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the road to the optimal treatment of lupus nephritis: are we there yet?
    Illei GG
    Lupus; 2005; 14(4):263-4. PubMed ID: 15864911
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe nephrotic syndrome with reversible acute kidney failure in lupus-associated membranous nephropathy].
    Pauli-Magnus C; Mettang T; Kuhlmann U
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):788-92. PubMed ID: 10414228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute renal failure as the initial presentation of systemic lupus erythematosus.
    Arbel O; Pizov G; Ben-Yehuda A; Rubinow A; Naparstek Y; Amital H
    Lupus; 2005; 14(4):331-3. PubMed ID: 15864922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
    Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
    Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and Treatment Outcomes of 100 Lupus Nephritis Patients: Single Center Study.
    Faroque MO; Hadiuzzaman KM; Islam SF; Hossain RM; Islam MN; Ahmed AH; Ahmed PI; Alam MR
    Mymensingh Med J; 2016 Apr; 25(2):308-15. PubMed ID: 27277365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.